Portable Artificial Kidney Trials Allowed In The U.S.
Food and Drug Administration of the United States (FDA) has given permission to conduct clinical trials of a portable artificial kidney Wearable Artificial Kidney (WAK).
It is expected that clinical trials of the new device will begin this fall in Seattle. Portable artificial kidney, developed in the University of California, is a compact dialysis machine, which is attached to a special belt. In contrast to the permanent installation, the new device is running on battery and does not need a fixed connection to the source of power. Innovation weighs about 4.5 kg, but the developers plan to reduce its weight and size in the future.
During Phase I of clinical trials the safety and performance of WAK will be assessed. The study will involve sixteen patients who will be observed for at least 28 days. The development of a portable device took more than ten years.
According to the creators, the new device will improve the quality of life for patients with renal failure and allow them to be more independent and active.
- Long Term Blood Sugar Management Delayed Kidney Issues
- Finding Clinical Trials For Crohn's Disease
- United States Test A Unique Cold Medicine